{"id":241895,"date":"2012-02-29T00:18:18","date_gmt":"2012-02-29T00:18:18","guid":{"rendered":"http:\/\/www.eugenesis.com\/georgia-research-alliance-names-first-eminent-scholar-in-nanomedicine\/"},"modified":"2012-02-29T00:18:18","modified_gmt":"2012-02-29T00:18:18","slug":"georgia-research-alliance-names-first-eminent-scholar-in-nanomedicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/georgia-research-alliance-names-first-eminent-scholar-in-nanomedicine.php","title":{"rendered":"Georgia Research Alliance Names First Eminent Scholar in Nanomedicine"},"content":{"rendered":"<p><p>    ATLANTA--(BUSINESS WIRE)--  <\/p>\n<p>    Younan Xia, Ph.D., an internationally recognized leader in the    field of nanotechnology, recently joined the Georgia Institute    of Technology as the first Georgia Research Alliance (GRA)    Eminent Scholar in Nanomedicine.  <\/p>\n<p>    Dr. Xia is the Brock Family Chair and GRA Eminent Scholar in    Nanomedicine in the Wallace H. Coulter Department of Biomedical    Engineering at Georgia Tech and Emory University, with a joint    appointment in the School of Chemistry and Biochemistry. His    research focuses on nanocrystals -- a novel class of materials    with features smaller than 100 nanometers -- as well as the    development of innovative technologies enabled by nanocrystals.    One nanometer is equal to one billionth of a meter. These    technologies span the fields of molecular imaging, early cancer    diagnosis, targeted drug delivery, biomaterials, regenerative    medicine and catalysis.  <\/p>\n<p>    \u201cThe possible applications of nanotechnology in medicine have    only begun to be explored,\u201d said Michael Cassidy, president and    CEO of the Georgia Research Alliance. \u201cDr. Xia\u2019s expertise and    collaborative vision will lead to vital new scientific    discoveries that can be transformed into new tools to help    people live healthier lives.\u201d  <\/p>\n<p>    Dr. Xia is an international leader in the synthesis of    nanomaterials designed to improve the way we live. He has been    ranked as one of the top 10 chemists in the world, as well as    the second most cited scientist in the fields of nanomedicine    and materials science.  <\/p>\n<p>    \u201cDr. Xia is a world-renowned teacher and leader at the    forefront of nanomedicine and materials science,\u201d said Larry    McIntire, the Wallace H. Coulter Chair of Biomedical    Engineering. \u201cHis reputation and innovative research in these    areas will clearly strengthen our expanding efforts in    nanomedicine and biomaterials. We are honored to welcome him to    the Department and to the Institute.\u201d  <\/p>\n<p>    Regents' Professor and Chair of Chemistry and Biochemistry    Charles Liotta said, \u201cDr. Xia is an outstanding addition to our    faculty in the School of Chemistry and Biochemistry. His    research in nanomedicine and biomaterials lies at the interface    between chemistry and engineering and fits in so well with the    interdisciplinary culture at Georgia Tech. Dr. Xia\u2019s presence    will clearly enhance our efforts in these critical research    areas.\u201d  <\/p>\n<p>    Dr. Xia received his Ph.D. in physical chemistry from Harvard    University (with Professor George M. Whitesides) in 1996, his    M.S. in inorganic chemistry from University of Pennsylvania    (with the late Professor Alan G. MacDiarmid, a Nobel Laureate    in Chemistry, 2000) in 1993. He has received a number of    prestigious awards, including AIMBE Fellow (2011), MRS Fellow    (2009), NIH Director's Pioneer Award (2006), Leo Hendrik    Baekeland Award (2005), Camille Dreyfus Teacher Scholar (2002),    David and Lucile Packard Fellowship in Science and Engineering    (2000), Alfred P. Sloan Research Fellow (2000), NSF Early    Career Development Award (2000) and the ACS Victor K. LaMer    Award (1999).  <\/p>\n<p>    About GRA  <\/p>\n<p>    A model public-private partnership between Georgia    universities, business and state government, the Georgia    Research Alliance helps build Georgia\u2019s technology-rich economy    in three major ways: through attracting Eminent Scholars to    Georgia\u2019s research universities; through investing in    sophisticated research tools; and through converting research    into products, services and jobs that drive the economy. To    learn more about GRA, visit     <a href=\"http:\/\/www.gra.org\" rel=\"nofollow\">http:\/\/www.gra.org<\/a>.  <\/p>\n<p>    About Georgia Tech  <\/p>\n<p>    The Georgia Institute of Technology is one of the world's    premier research universities. Ranked seventh    among&nbsp;U.S. News &amp; World Report's&nbsp;top    public universities, the Institute enrolls more than 20,000    students within its six colleges. Georgia Tech is the nation's    leading producer of engineers as well as a leading producer of    female and minority engineering Ph.D. graduates. Holding more    than 780 patents and receiving approximately $570 million in    sponsored awards, Georgia Tech ranks among the nation's top    universities in research expenditures. Visit&nbsp;www.gatech.edu&nbsp;for    more information.  <\/p>\n<\/p>\n<p>See original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/georgia-research-alliance-names-first-165200863.html\" title=\"Georgia Research Alliance Names First Eminent Scholar in Nanomedicine\">Georgia Research Alliance Names First Eminent Scholar in Nanomedicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> ATLANTA--(BUSINESS WIRE)-- Younan Xia, Ph.D., an internationally recognized leader in the field of nanotechnology, recently joined the Georgia Institute of Technology as the first Georgia Research Alliance (GRA) Eminent Scholar in Nanomedicine. Dr.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/georgia-research-alliance-names-first-eminent-scholar-in-nanomedicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577469],"tags":[],"class_list":["post-241895","post","type-post","status-publish","format-standard","hentry","category-biochemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/241895"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=241895"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/241895\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=241895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=241895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=241895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}